Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $1,987,524 | $1,966,038 | $2,424,630 | $2,397,408 |
| - Cash | $759,932 | $360,266 | $480,300 | $748,834 |
| + Debt | $25,588 | $14,031 | $16,848 | $21,359 |
| Enterprise Value | $1,253,180 | $1,619,803 | $1,961,179 | $1,669,932 |
| Revenue | $1,022,877 | $141,706,000 | $128,330,000 | $1,077,966 |
| % Growth | -99.3% | 10.4% | 11,804.8% | – |
| Gross Profit | $597,940 | $78,971,000 | $541,829 | $628,405 |
| % Margin | 58.5% | 55.7% | 0.4% | 58.3% |
| EBITDA | $229,784 | $24,376,000 | $157,123 | $17,297,000 |
| % Margin | 22.5% | 17.2% | 0.1% | 1,604.6% |
| Net Income | $142,660 | $13,969,000 | $87,520 | $9,658,000 |
| % Margin | 13.9% | 9.9% | 0.1% | 895.9% |
| EPS Diluted | 0.48 | 0.32 | 0.28 | 0.27 |
| % Growth | 50% | 14.3% | 3.7% | – |
| Operating Cash Flow | $123,036 | $18,188,000 | $94,854 | $172,189 |
| Capital Expenditures | -$89,347 | -$13,036,000 | -$58,938 | -$37,605 |
| Free Cash Flow | $33,688 | $5,152,000 | $35,916 | $134,583 |